Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
We know from a number of older, epidemiologic studies that there seems to be an inverse association between diabetes status and prostate cancer risk. In other words, people with diabetes seem to be less likely to be diagnosed with prostate cancer.
Filed under: Diagnosis, Prevention, Risk | Tagged: allele, diabetes, genetics, genome, risk | Leave a Comment »
It has long been recognized that the combination of prostate cancer and diabetes tends to have a notable impact on the health-related quality of life (HRQoL) of male patients.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diabetes, HRQOL, quality of life | Leave a Comment »
Today’s news reports address: Diabetes and prostate cancer risk among Japanese men The accuracy of T2w ecMRI in detection of prostate cancer Escalated dose radiation therapy and treatment of localized prostate cancer Erectile dysfunction and penile rehabilitation post-surgery
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diabetes, endorectal coil, erectile dysfunction, MRI, penile rehabilitation, radiotherapy, risk | Leave a Comment »
In this weekend’s prostate cancer news reports, we have addressed recent publications on: A SNP that may be specifically linked to risk for prostate cancer in African Americans The need for extended biopsies in men with larger prostates who are considering focal treatment for prostate cancer A possible association between diabetes, race, obesity, and risk [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, age, biopsy, brachytherapy, diabetes, focal, hormone therapy, mortality, neoadjuvant, obesity, race, single nucleotide polymorphism, SNP, Treatment | Leave a Comment »
Today’s news reports deal with: Diabetes, PSA, and prostate cancer risk Magnetic resonance spectroscopic imaging Ongoing trials of dutasteride as early stage treatment for prostate cancer
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, diabetes, dutasteride, magmentic resonance spectroscopic imaging, MSRI, REDEEM, risk | Leave a Comment »
A recently published study has suggested the possibility of an association between the aggressiveness of prostate cancer and degree of glycemic control in some patients with an existing diagnosis of diabetes.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aggressiveness, diabetes, glycemic control, HbA1c | Leave a Comment »
As reported by Reuters Health earlier today, the majority of men with early-stage, low- or moderate-grade prostate cancer do not, in fact die from this disease. This topic has been carefully addressed by a recent article in the January issue of the Journal of the American Geriatric Society. Prevention and management of other health conditions [...]
Filed under: Living with Prostate Cancer, Management | Tagged: cardiovascular risk, diabetes, mortality, obesity, survival | Leave a Comment »
Today being December 31, this will be the final daily news report of the first calendar year of existence for The “New” Prostate Cancer InfoLink. There are three reports covered in the news below, the most important of which supports the idea that men with diabetes have a reduced risk for prostate cancer.
Filed under: Diagnosis, Risk, Treatment | Tagged: conformal arc, diabetes, genes, image-guided, radiotherapy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site